論文

査読有り 筆頭著者 責任著者
2020年5月

Characteristics and course of patients treated with Kampo Medicine in the Department of General Medicine.

Journal of general and family medicine
  • Shin Takayama
  • Tetsuya Akaishi
  • Hiroyuki Nozaki
  • Satoko Suzuki
  • Ryutaro Arita
  • Natsumi Saito
  • Junichi Tanaka
  • Takehiro Numata
  • Akiko Kikuchi
  • Minoru Ohsawa
  • Michiaki Abe
  • Tadashi Ishii
  • 全て表示

21
3
開始ページ
48
終了ページ
55
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1002/jgf2.294
出版者・発行元
Wiley

Background: A recent investigation reported that 92.7% Japanese family physicians have prescribed Kampo medicine (KM). KM can treat a wide variety of conditions from mental disorders to physical weaknesses. However, the characteristics and course of patients treated with KM at the Department of General Medicine remain unclear. Aims: To investigate the characteristics and course of patients treated with KM in our hospital. Methods: Data on medical history, complaints, course after Kampo treatment, and Hamilton Depression Rating Scale (HAM-D) scores were retrogradely collected. The background of patients who received Kampo treatment was compared to that of patients who did not. Result: Of 362 patients, 51 were treated with KM. Symptoms for which KM was prescribed included pain, general malaise, or sensory disturbance of extremities. All patients treated with KM were screened and initially diagnosed with a functional disorder or noncritical condition. KM including a crude drug of saiko such as hochuekkito, shigyakusan, shosaikoto, and yokukansan, was frequently prescribed for patients. Subjective symptoms showed improvement (53%) and no change (47%), while worsening was not observed in any patient. HAM-D scores showed that patients treated with KM had higher anxiety levels and related symptoms as well as a higher frequency of mental disorders prior to presenting at the hospital. Conclusion: Most complaints of the patients treated with KM were pain, general malaise, and sensory disturbance. KM is more likely to be prescribed in patients with health-related anxiety or a history of mental disorders.

リンク情報
DOI
https://doi.org/10.1002/jgf2.294
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32489756
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260161
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000515336700001&DestApp=WOS_CPL
Scopus
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85095767159&origin=inward 本文へのリンクあり
Scopus Citedby
https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85095767159&origin=inward
ID情報
  • DOI : 10.1002/jgf2.294
  • ISSN : 2189-7948
  • eISSN : 2189-7948
  • ORCIDのPut Code : 69424408
  • PubMed ID : 32489756
  • PubMed Central 記事ID : PMC7260161
  • SCOPUS ID : 85095767159
  • Web of Science ID : WOS:000515336700001

エクスポート
BibTeX RIS